MANF Gene

Introduction

flowchart TD
    MANF["MANF"] -->|"binds to"| PRKN["PRKN"]
    MANF["MANF"] -->|"promotes"| mitophagy["mitophagy"]
    MANF["MANF"] -->|"associated with"| breast_cancer_cell_survival["breast cancer cell survival"]
    MANF["MANF"] -->|"interacts with"| PRKN["PRKN"]
    MANF["MANF"] -->|"associated with"| PRKN_E3_ligase_activity["PRKN E3 ligase activity"]
    MANF["MANF"] -->|"activates"| PRKN["PRKN"]
    MANF["MANF"] -->|"therapeutic target"| breast_cancer["breast cancer"]
    MANF["MANF"] -->|"activates"| mitophagy["mitophagy"]
    MANF["MANF"] -->|"promotes"| fatty_acid_oxidation["fatty acid oxidation"]
    MANF["MANF"] -->|"associated with"| fatty_acid_oxidation["fatty acid oxidation"]
    MANF["MANF"] -->|"binds"| PARK2["PARK2"]
    MANF["MANF"] -->|"expressed in"| NEURON["NEURON"]
    MANF["MANF"] -->|"regulates"| Oxidative_Stress["Oxidative Stress"]
    MANF["MANF"] -->|"activates"| Als["Als"]
    style MANF fill:#4fc3f7,stroke:#333,color:#000

The MANF gene (Mesencephalic Astrocyte-Derived Neurotrophic Factor), also known as ARMET (Arginine-rich, Mutated in Early stage Tumors), encodes a unique neurotrophic factor with distinctive mechanisms of action distinct from classical neurotrophic factors like BDNF or GDNF. Discovered in 2003, MANF has emerged as a promising therapeutic target for multiple neurodegenerative conditions, particularly Parkinson’s disease, Alzheimer’s disease, stroke, and amyotrophic lateral sclerosis^{1MANF: a neurotrophic factor with therapeutic potential in Parkinson's disease2020 · Journal of Parkinson's Disease · PMID 32651323Open reference2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}.

Unlike traditional neurotrophic factors that signal through specific receptor tyrosine kinases, MANF exerts its neuroprotective effects primarily through modulation of endoplasmic reticulum (ER) stress responses and direct chaperone activity. This unique mechanism positions MANF as a particularly attractive therapeutic agent for diseases characterized by protein misfolding and ER dysfunction

Gene Structure and Organization

The MANF gene spans approximately 5.2 kb and consists of 4 exons encoding a 182-amino acid protein. The gene structure reveals several important features:

• Exon 1: Encodes the signal peptide and N-terminal portion

• Exon 2-4: Encode the C-terminal secreted domain with cysteine-rich regions

The promoter region contains multiple regulatory elements including:

• ATF4 response elements (amino acid response)

• ER stress response elements (UPRE)

• Antioxidant response elements (ARE)

Expression is induced by various cellular stresses including:

• Amino acid deprivation

• ER stress

• Oxidative stress

• Ischemia

• Neuroinflammation^{4MANF is widely expressed in mammalian tissues and is induced by oxidative stress2022 · Journal of Molecular Neuroscience · PMID 35606672Open reference}

Protein Structure and Function

Domain Architecture

MANF possesses a distinctive bipartite structure critical for its function:

N-terminal ER Retention Domain (1-60 aa):

• Contains RTDL sequence for ER localization

• Arginine-rich region for protein-protein interactions

• Direct binding to misfolded proteins

• Interaction with BiP/GRP78 chaperone

C-terminal Secreted Domain (61-182 aa):

• Four conserved cysteine residues forming disulfide bonds

• Novel protein fold distinct from other neurotrophic factors

• Neurotrophic activity region

• Receptor binding domain

Molecular Mechanisms

MANF operates through multiple molecular pathways^{5MANF and the unfolded protein response in neurodegeneration2022 · Cellular and Molecular Neurobiology · PMID 34978091Open reference6MANF receptor identification and signaling mechanisms2020 · Cellular Signalling · PMID 31655278Open reference}:

1. ER Stress Modulation:

• Direct chaperone activity on misfolded proteins

• Stabilization of ER membrane integrity

• Interaction with BiP/GRP78 to regulate UPR

• Modulation of PERK, IRE1, and ATF6 pathways

2. PI3K/Akt Signaling:

• Activation promotes cell survival

• Phosphorylation of BAD

• mTORC1 activation

• Critical for dopaminergic neuron survival

3. MAPK/ERK Pathway:

• Stimulation of neuronal differentiation

• Plasticity mechanisms

• Anti-apoptotic effects

4. NF-κB Inhibition:

• Suppression of neuroinflammation

• Reduced cytokine production

• Protection in PD and AD models^{7The role of MANF in neuroinflammation2024 · Journal of Neuroinflammation · PMID 38355516Open reference}

Normal Function in the Nervous System

Expression Patterns

MANF shows widespread and region-specific expression in the nervous system^{4MANF is widely expressed in mammalian tissues and is induced by oxidative stress2022 · Journal of Molecular Neuroscience · PMID 35606672Open reference8MANF expression in human substantia nigra of Parkinson's disease2018 · Neuroscience Letters · PMID 29378125Open reference}:

Cellular Sources:

• Neurons: Constitutive expression, upregulated by stress

• Astrocytes: Major source of secreted MANF

• Microglia: Inducible expression during inflammation

Physiological Roles

Neuroprotection:

• Protects against 6-OHDA, MPTP, rotenone toxicity

• Protects against amyloid-beta oligomers

• Preserves mitochondrial membrane potential

• Maintains ATP production

Synaptic Function:

• Modulates synaptic vesicle release

• Regulates dendritic spine morphology

• Promotes synaptic plasticity

ER Homeostasis:

• Chaperone-like activity

• UPR modulation

• Calcium homeostasis

Role in Neurodegenerative Diseases

Parkinson’s Disease

MANF is highly relevant to Parkinson’s disease pathogenesis^{1MANF: a neurotrophic factor with therapeutic potential in Parkinson's disease2020 · Journal of Parkinson's Disease · PMID 32651323Open reference2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}0^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}1:

Expression Alterations:

• MANF mRNA reduced in PD substantia nigra

• Protein levels decreased in striatum

• Correlate with disease severity

Protective Mechanisms:

• AAV-MANF delivery protects dopaminergic neurons

• 6-OHDA lesion model shows neuroprotection

• MPTP model demonstrates attenuation of degeneration

• Reduces neuroinflammation

Genetic Associations:

• Promoter variants associated with PD risk

• SNP rs12765680 correlates with earlier onset^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}2

Therapeutic Potential:

• AAV-MANF gene therapy in clinical development

• Recombinant protein delivery

• Small molecule MANF inducers

Alzheimer’s Disease

MANF dysfunction contributes to Alzheimer’s disease through several mechanisms^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}3:

Pathological Involvement:

• MANF levels reduced in AD hippocampus

• Protects against Aβ oligomer toxicity

• May enhance Aβ clearance via autophagy

• Reduces ER stress in neurons with pathology

Therapeutic Implications:

• MANF overexpression improves cognition in AD models

• Reduces amyloid plaque burden

• Protects synaptic function

Stroke and Ischemia

MANF is strongly upregulated following cerebral ischemia^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}4:

Response to Injury:

• Expression increases 4-8 hours post-infarct

• Peaks at 24-48 hours

• Continues for several days

Protective Effects:

• Reduces infarct size

• Improves functional recovery

• Promotes angiogenesis

• Protects blood-brain barrier

Mechanisms:

• ER stress protection

• Anti-apoptotic signaling

• Anti-inflammatory effects

Amyotrophic Lateral Sclerosis

In ALS, MANF shows altered expression in motor neurons and astrocytes^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}5:

Expression Changes:

• Elevated in ALS motor neurons

• Astrocytic MANF increased

• May reflect attempted neuroprotection

Therapeutic Potential:

• Protects motor neurons from excitotoxicity

• Modulates astrocyte-mediated inflammation

• Gene therapy approaches under investigation

Glioblastoma

Recent research reveals MANF involvement in glioblastoma^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}6:

• Anti-tumor effects

• Induction of apoptosis in glioma cells

• Potential therapeutic targeting

Therapeutic Implications

Gene Therapy

AAV-mediated MANF delivery represents a promising approach^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}7:

Delivery Methods:

• AAV serotype 2/9 for CNS targeting

• Intraparenchymal injection

• Systemic delivery with BBB-penetrant vectors

Preclinical Results:

• Sustained MANF expression

• Protected dopaminergic neurons

• Improved motor function

• No adverse effects observed

Protein Therapy

Recombinant MANF protein delivery^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}8:

• Modified for BBB penetration

• Extended half-life formulations

• Direct injection or nanoparticle delivery

• Demonstrated neuroprotection in models

Small Molecule Inducers

Pharmacological upregulation of endogenous MANF:

• Valproic acid increases MANF expression

• TUDCA (tauroursodeoxycholic acid) elevates MANF

• GSK3β inhibitors enhance expression

Biomarker Potential

MANF as a biomarker for neurodegeneration^{2MANF deficiency contributes to dopaminergic neuron degeneration2023 · Cell Death & Disease · PMID 36725965Open reference}9:

• Detectable in cerebrospinal fluid

• Reduced in PD and AD patients

• Potential for disease progression monitoring

Animal Models

Research Directions

Current research priorities include:

1. Receptor Identification: Complete characterization of MANF receptor(s) and downstream signaling

2. Delivery Optimization: Developing efficient CNS delivery methods for MANF protein

3. Clinical Translation: Moving MANF therapies toward human clinical trials

4. Biomarker Development: MANF as a biomarker for diagnosis and progression

5. Combination Therapies: MANF with other neurotrophic factors or disease-modifying drugs

6. Genetic Variants: Understanding how MANF variants affect disease risk and progression^{3MANF secretory loop peptides are required for ER stress protection2021 · Journal of Molecular Biology · PMID 34247521Open reference}0

Cross-References

• MANF Protein — Protein detailed page

• Parkinson’s Disease — Associated disorder

• Alzheimer’s Disease — Associated disorder

• Neurotrophic Factors — Pathway overview

• Dopaminergic Neurons — Target cell type

• ER Stress Pathway — Key mechanism

• Mitochondrial Dysfunction Pathway — Related pathway

• Stroke — Associated disorder

• Amyotrophic Lateral Sclerosis — Associated disorder

External Resources

• NCBI Gene: MANF

• UniProt: MANF (Q99986)

• Human Protein Atlas: MANF

• Ensembl: MANF

• GeneCards: MANF

Pathway Diagram

The following diagram shows the key molecular relationships involving MANF Gene discovered through SciDEX knowledge graph analysis:

graph TD
    SENP1["SENP1"] -->|"de-SUMOylates"| MANF["MANF"]
    SENP1["SENP1"] -->|"modulates"| MANF["MANF"]
    Bpmc["Bpmc"] -.->|"downregulates"| MANF["MANF"]
    SENP1["SENP1"] -->|"modifies"| MANF["MANF"]
    OXIDATIVE_STRESS["OXIDATIVE STRESS"] -->|"regulates"| MANF["MANF"]
    GPX4["GPX4"] -->|"biomarker for"| MANF["MANF"]
    CAT["CAT"] -->|"biomarker for"| MANF["MANF"]
    ELAVL3["ELAVL3"] -.->|"inhibits"| MANF["MANF"]
    UBIQUITIN["UBIQUITIN"] -->|"regulates"| MANF["MANF"]
    PARKIN["PARKIN"] -->|"regulates"| MANF["MANF"]
    PRKN["PRKN"] -->|"regulates"| MANF["MANF"]
    TUBULIN["TUBULIN"] -.->|"inhibits"| MANF["MANF"]
    MBP["MBP"] -.->|"inhibits"| MANF["MANF"]
    TAU["TAU"] -->|"therapeutic target"| MANF["MANF"]
    SENP1["SENP1"] -->|"activates"| MANF["MANF"]
    style SENP1 fill:#ce93d8,stroke:#333,color:#000
    style MANF fill:#ce93d8,stroke:#333,color:#000
    style Bpmc fill:#ff8a65,stroke:#333,color:#000
    style OXIDATIVE_STRESS fill:#ce93d8,stroke:#333,color:#000
    style GPX4 fill:#ce93d8,stroke:#333,color:#000
    style CAT fill:#ce93d8,stroke:#333,color:#000
    style ELAVL3 fill:#ce93d8,stroke:#333,color:#000
    style UBIQUITIN fill:#ce93d8,stroke:#333,color:#000
    style PARKIN fill:#ce93d8,stroke:#333,color:#000
    style PRKN fill:#ce93d8,stroke:#333,color:#000
    style TUBULIN fill:#ce93d8,stroke:#333,color:#000
    style MBP fill:#ce93d8,stroke:#333,color:#000
    style TAU fill:#ce93d8,stroke:#333,color:#000